http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100523525-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
filingDate 2002-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100523525-B1
titleOfInvention Hybrid Materials For Stabilization And Delivery Of Drugs And Processes For Preparing The Same
abstract The present invention provides a drug delivery system having excellent stability, sustained release, and low side effects, and is a hybrid of a layered inorganic material and a drug selected from the group consisting of 3-benzoyl-α-methylbenzeneacetic acid, 4-biphenylacetic acid, and minocycline. To provide.n n n In addition, the present invention provides a method for producing the hybrid material using the coprecipitation method and the ion exchange method according to the properties of the drug. The method may further include coating a surface of the hybrid material.n n n The present invention also provides a pharmaceutical composition comprising the hybrid material.
priorityDate 2001-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451932064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21888974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449323691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56842000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5493302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11955398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414778444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453109149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559465

Total number of triples: 31.